Sterling Pharma Solutions granted MIA license for cGMP antibody-drug conjugate manufacturing at UK facility
CDMO Sterling Pharma Solutions has been granted a Manufacturer’s Authorisation for Investigational Medicinal Products from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).